PEAK6 Group’s Loxo Oncology, Inc LOXO Stock Holding History

PEAK6 Group’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,300	Closed	-$488K	–	5159
2017 Q3	$488K	Sell	5,300 -2,600	-33%	-$202K	﹤0.01%	2573
2017 Q2	$634K	Buy	+7,900	New	+$438K	﹤0.01%	2313

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

PEAK6 Group's LOXO Position: Q4 2017 in Review

PEAK6 Group sold out of Loxo Oncology, Inc (LOXO) in Q4 2017, closing a stake of 398 shares — an estimated $37K sold.

PEAK6 Group first reported a position in LOXO in Q2 2017 and held it in 2 quarters. The position peaked at $41K in Q2 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

PEAK6 Group reported no remaining Loxo Oncology, Inc position as of Q4 2017 after selling out during the quarter.
PEAK6 Group sold 398 Loxo Oncology, Inc shares in Q4 2017, an estimated $37K.
PEAK6 Group first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 2 quarters.
PEAK6 Group's Loxo Oncology, Inc position peaked at $41K in Q2 2017.
141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.